RECOMMENDING CANNABIS IN OKLAHOMA

 

The Oklahoma Medical Marijuana Authority (OMMA) oversees the Oklahoma Medical Marijuana Program, established through a voter-approved State Question 788 in 2018.  Patients and their caregivers must be registered with the program to benefit from the rights and protections granted under these statutes. 

 

Under Oklahoma statute and OMMA guidance, a physician is qualified to sign a physician recommendation form only when all of the following requirements are met:

  • The physician holds a valid license and is in good standing with the State Board of Medical Licensure and Supervision, the State Board of Osteopathic Examiners, or the State Board of Podiatric Medical Examiners.
  • The physician adheres to accepted standards that a reasonable and prudent physician would follow when recommending any medication to a patient.
  • The physician is not located at the same physical address as a dispensary, including during virtual appointments conducted while the patient is physically at a dispensary.
  • Effective January 1, 2026: The physician is registered with OMMA and has completed and submitted the required medical cannabis education under SB 1066 (2025).

Physicians must register with OMMA before issuing any patient recommendations. Registration is completed through the OMMA Physicians page. A list of currently registered physicians is maintained by OMMA and is available as a public document.

Education Requirements

Initial Education Requirement

Physicians must complete one approved medical cannabis CME course before registering with OMMA and issuing recommendations. Only one course is required; physicians do not need to complete multiple courses. OMMA identified approved courses in consultation with the State Board of Medical Licensure and Supervision, the State Board of Osteopathic Examiners, and the State Board of Podiatric Medical Examiners. For the current list of approved courses and accreditation details, visit the OMMA Physicians page.

Continuing Education (CME/CEU)

Physicians must renew their medical cannabis CME annually, one year from the date of their initial submission. Only one approved course is required per renewal cycle. The OMMA Physicians page maintains the current list of approved courses and their accreditation expiration dates. Physicians should confirm the accreditation status of any course before completing it for renewal credit.

Oklahoma does not impose a fixed list of qualifying conditions. Any licensed, registered physician may recommend cannabis for any condition they deem appropriate, applying accepted clinical standards. Commonly recommended conditions include:

      • Alzheimer's disease
      • Amyotrophic lateral sclerosis (ALS)
      • Autism spectrum disorder (must meet DSM-5)
      • Cancer (*If the illness or its treatment produces one or more of the following: severe or chronic pain; nausea or severe vomiting; or cachexia or severe wasting)
      • Chronic motor or vocal tic disorder
      • Chronic pain
      • Glaucoma
      • HIV/AIDS
      • Inflammatory bowel disease, including Crohn’s disease
      • Intractable Pain
      • Irritable bowel syndrome
      • Obsessive-compulsive disorder
      • Obstructive Sleep Apnea
      • Post-traumatic stress disorder (PTSD)
      • Seizures, including those characteristic of epilepsy
      • Severe and persistent muscle spasms, including those characteristic of multiple sclerosis (MS)
      • Sickle cell disease
      • Terminal illness, with a probable life expectancy of less than one year*
      • Tourette syndrome
      • Any medical condition for which a patient’s health care practitioner has recommended, approved, or authorized the use of cannabis by that individual to treat the condition.

Step 1: Evaluate the patient.

The physician must adhere to accepted standards that a reasonable and prudent physician would follow when recommending any medication to a patient. No specific telehealth or in-person evaluation requirement is codified in the statute for initial recommendations; however, virtual appointments are prohibited if the physician is located at the same physical address as a dispensary or if the patient is physically present at a dispensary during the appointment. Verify current telehealth permissibility with OMMA or your licensing board before conducting remote evaluations.

Step 2: Complete the recommendation form.

Complete and sign the Adult Patient Physician Recommendation Form (or the Minor Patient Physician Recommendation Form for patients under age 18). The form must be dated within 30 days of the patient’s application submission date. The physician provides the signed form directly to the patient for submission with their OMMA application; physicians do not submit the form independently to OMMA. For minor patients, two physician signatures are required.

Step 3: Certify caregiver need (if applicable).

If the patient is homebound or is unable to self-administer or purchase cannabis due to a developmental disability or physical or mental condition, the physician may complete the optional Certification of Necessity of a Caregiver section of the recommendation form. This certification enables the patient to designate a licensed caregiver.

Step 4: Maintain records.

Document the evaluation, clinical basis for the recommendation, and issuance of the recommendation form in the patient's medical record, consistent with your licensing board's documentation standards.

Patient licenses are valid for up to two years.

At renewal, the patient must submit a new application with a new physician recommendation form dated within 30 days of the renewal application date. There is no separate recertification interval shorter than the two-year license term. For more information, see the OMMA Patient Licenses page.

Medical professionals have a legal right to recommend cannabis as a treatment in any state, as protected by the Medical Marijuana and Cannabidiol Research Expansion Act (Title III section 301) which became law on December 2, 2022, and the First Amendment (established by a 2004 United States Supreme Court decision to uphold earlier federal court rulings that doctors, and their patients have a fundamental Constitutional right to freely discuss treatment options).

DOWNLOAD MEDICAL PROFESSIONALS, MEDICAL CANNABIS & THE LAW 

 

 

State-by-state compassionate use programs are not the ultimate goal for medical cannabis patients; they are a means to aid patients in finding safe cannabis products until federal laws change. Americans for Safe Access is working to create a national program that would include prescriptions, standardized products, and a pathway to insurance coverage. Learn more about ASA Campaigns.

*UPDATE: FEDERAL CANNABIS LAWS HAVE CHANGED AS OF APRIL 28, 2026: Learn more here.

More resources for medical professionals are available here.

If you appreciate ASA's work, join now to become a part of the movement & sign up to get ASA updates.